Michael John Sumner - 20 May 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Medical Officer
Signature
/s/ Michael John Sumner
Issuer symbol
INO
Transactions as of
20 May 2025
Net transactions value
$0
Form type
4
Filing time
21 May 2025, 16:57:22 UTC
Previous filing
16 May 2025
Next filing
01 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sumner Michael John Chief Medical Officer 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING /s/ Michael John Sumner 21 May 2025 0001936799

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Award $0 +28,350 $0.000000 28,350 20 May 2025 Common Stock 28,350 Direct F1
transaction INO Common Stock Option Award $0 +35,100 $0.000000 35,100 20 May 2025 Common Stock 35,100 $2.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units is as follows: 9,450 shares will vest on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The vesting schedule for the 31,500 options is as follows: 17,550 shares will vest on May 20, 2027 and 17,550 shares will vest on May 20, 2028.